Published in Ann Oncol on October 11, 2007
Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study. BMC Cancer (2008) 1.58
Primary breast lymphoma - a review of the literature and report of three cases. Arch Med Sci (2011) 1.43
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL). J Hematol Oncol (2012) 1.37
Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study. BMC Cancer (2010) 1.14
Primary breast lymphomas: a multicentric experience. World J Surg Oncol (2010) 1.13
Lymphoma affecting the breast: a pictorial review of multimodal imaging findings. J Breast Cancer (2013) 1.02
Primary malignant non-Hodgkin's lymphoma of the breast: a study of seven cases and literature review. World J Surg Oncol (2012) 0.93
Lymphoma of the breast: a mimic of inflammatory breast cancer. World J Surg Oncol (2011) 0.88
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol (2014) 0.86
Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes. Onco Targets Ther (2016) 0.83
Primary malignant non-Hodgkin's lymphoma of the breast: A case report. Oncol Lett (2014) 0.80
Primary non-Hodgkin's breast lymphoma: Surgical approach. Cases J (2008) 0.78
Primary breast diffuse large B cell lymphoma - report of 6 cases from South India with review of literature. Indian J Surg Oncol (2013) 0.78
A Case of Primary Breast Diffuse Large B-Cell Lymphoma Treated with Chemotherapy Followed by Elective Field Radiation Therapy: A Brief Treatment Pattern Review from a Radiation Oncologist's Point of View. Case Rep Oncol Med (2015) 0.78
A Challenging Case of Primary Breast Hodgkin's Lymphoma. Maedica (Buchar) (2015) 0.78
Clinical features and outcome of primary pancreatic lymphoma. Ann Surg Oncol (2014) 0.77
Primary breast lymphoma: a single institution's experience. J Korean Surg Soc (2013) 0.76
Primary Breast Lymphoma in a Woman: A Case Report and Review of the Literature. Am J Case Rep (2016) 0.75
Diffuse Large B-Cell Lymphoma with Involvement of the Breast and Testis in a Male Patient. Cancer Res Treat (2014) 0.75
Diffuse large B-cell lymphoma of the breast: a distinct entity? Ann Oncol (2008) 0.75
Primary breast lymphoma: A single center study. Oncol Lett (2016) 0.75
Primary breast lymphoma in males-a report of two cases with a review of the literature. Ecancermedicalscience (2013) 0.75
Rare lymphoid malignancies of the breast: report of two cases illustrating potential diagnostic techniques. J Radiol Case Rep (2012) 0.75
Spontaneous regression of a clinically-advanced histologically low-grade follicular lymphoma involving the breast: case report and review of the literature. Indian J Hematol Blood Transfus (2014) 0.75
Breast lymphoma. Ann Oncol (2008) 0.75
Primary breast diffuse large B-cell lymphoma in the era of rituximab. Onco Targets Ther (2016) 0.75
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest (1975) 6.25
Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections. Intern Med J (2004) 4.70
The physician's actions and the outcome of illness in family practice. J Fam Pract (1986) 4.41
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients. Br J Cancer (2007) 3.61
Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin. Biochim Biophys Acta (1970) 3.31
Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med (1975) 3.24
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood (2001) 3.24
Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood (1997) 3.19
Infectious viral DNA of murine leukemia virus. Proc Natl Acad Sci U S A (1975) 3.09
Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus. Proc Natl Acad Sci U S A (1975) 3.07
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer (1998) 3.03
Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol (1997) 2.87
gamma-beta-Thalassaemia studies showing that deletion of the gamma- and delta-genes influences beta-globin gene expression in man. Nature (1980) 2.68
A test of the nature of cosmic acceleration using galaxy redshift distortions. Nature (2008) 2.65
Validation of cardiac output studies from the Mostcare compared to a pulmonary artery catheter in septic patients. Minerva Anestesiol (2014) 2.65
The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature (1988) 2.65
Endotracheal tube introducer for failed intubations: a variant of the gum elastic bougie. Ann Emerg Med (2000) 2.65
Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med (1995) 2.64
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet (1993) 2.57
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood (2002) 2.57
Purification of two high molecular weight proteases from rabbit reticulocyte lysate. J Biol Chem (1987) 2.54
Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med (2006) 2.43
Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood (1995) 2.39
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. J Clin Oncol (2005) 2.39
Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem (1992) 2.35
Study of the genetic transmission of hypercholesterolemia and hypertriglyceridemia in a 195 member kindred. Ann Hum Genet (1975) 2.32
Functional activity of enucleated human polymorphonuclear leukocytes. J Cell Biol (1983) 2.32
Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A (2000) 2.26
Sunlight and cataract: an epidemiologic investigation. Am J Epidemiol (1977) 2.23
A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party. Leuk Lymphoma (1992) 2.23
Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res (2001) 2.17
Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood (1996) 2.17
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol (2003) 2.16
Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study. J Lab Clin Med (1974) 2.14
Spinal cord injury caused by direct damage by local anaesthetic infiltration needle. Br J Anaesth (2001) 2.06
Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood (1991) 2.05
Production of hydrogen peroxide by phagocytizing human granulocytes. J Lab Clin Med (1975) 2.05
A multicenter study of treatment of primary CNS lymphoma. Neurology (2002) 2.04
Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Ann Oncol (2010) 2.02
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia (2010) 1.97
Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant (2000) 1.95
Partially single-stranded form of free Moloney viral DNA. Nature (1975) 1.93
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol (2000) 1.92
Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol (2000) 1.91
Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group. Ann Intern Med (1991) 1.88
Globin gene deletion in HPFH, delta (o) beta (o) thalassaemia and Hb Lepore disease. Nature (1979) 1.88
Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II. Relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation. Exp Cell Res (1973) 1.87
Epidemiology of hematological malignancies. Ann Oncol (2007) 1.87
Brominating oxidants generated by human eosinophils. Science (1986) 1.86
Actin filament polymerization regulates gliding motility by apicomplexan parasites. Mol Biol Cell (2003) 1.85
Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa. Leukemia (2003) 1.84
Multiple forms of the 20 S multicatalytic and the 26 S ubiquitin/ATP-dependent proteases from rabbit reticulocyte lysate. J Biol Chem (1992) 1.81
Identification by 16S ribosomal RNA gene sequencing of an Enterobacteriaceae species with ambiguous biochemical profile from a renal transplant recipient. Diagn Microbiol Infect Dis (2001) 1.80
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol (2000) 1.79
Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol (1996) 1.79
Modification of the system of screening for antisyphilis antibodies in a blood transfusion centre, featuring a miniaturisation of the Treponema pallidum haemagglutination assay. J Clin Pathol (1982) 1.77
Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. Br J Haematol (1999) 1.77
Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol (1992) 1.76
North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet (1998) 1.75
Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell (1999) 1.74
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol (2006) 1.74
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy. Ann Oncol (2002) 1.73
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma. Ann Intern Med (1997) 1.71
Ubiquitin-lysozyme conjugates. Identification and characterization of an ATP-dependent protease from rabbit reticulocyte lysates. J Biol Chem (1986) 1.70
Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer. Ann Oncol (1996) 1.70
Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients. Ann Oncol (1995) 1.69
Risk factors for postmenopausal osteoporosis. Am J Med (1985) 1.68
Randomized trials: what's the problem? Ann Oncol (1992) 1.68
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders. Blood (2001) 1.67
Outcome of special types of luminal breast cancer. Ann Oncol (2011) 1.67
Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J Clin Invest (1978) 1.66
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol (2000) 1.66
Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. Blood (1989) 1.66
Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ (2004) 1.65
Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64
Adolescent and young adult cancer: a revolution in evolution? Intern Med J (2006) 1.64
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. Leukemia (2009) 1.63
Subunit 4 of the 26 S protease is a member of a novel eukaryotic ATPase family. J Biol Chem (1992) 1.63
The 40-kDa Fc gamma receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J Immunol (1989) 1.63
Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med (2000) 1.63
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol (1997) 1.61
Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency. Blood (1979) 1.60
Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood (1990) 1.59
Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. Ann Oncol (1997) 1.58
Purification and cryopreservation of phagocytes from human blood. Methods Enzymol (1986) 1.58
Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J Immunol (2000) 1.57
Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci (1999) 1.57